When deprescribing medications for hospice patients, providers have to navigate a complex web of factors. But according to some clinicians, the prospect of cost savings often takes precedence over clinical outcomes. Medication costs are among hospices’ biggest expenses, and deprescribing some medications deemed “curative” or “unrelated” to the patient’s terminal diagnosis is a standard practice. […]
Public policy intended to reduce opioid abuse and addiction appear to have the unintended consequence of limiting hospice patients’ access to these often necessary pain management drugs. Misapplication of current U.S. Centers for Disease Control & Prevention (CDC) guidelines for opioid prescribing is a likely contributor to this problem. Recent research spearheaded by the Oregon […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
